SCHEMBL4448254

SCHEMBL4448254

COC(=O)c1cc(C(F)(F)F)ccc1Sc1ccc(F)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.49
MPO P05164 1/20 0.45
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
USP2 O75604 1/20 0.42
CYP2C19 P33261 1/20 0.42
LIPG Q9Y5X9 2/20 0.41
FKBP1A P62942 1/20 0.41
GRIK1 P39086 1/20 0.40
SORT1 Q99523 3/20 0.40
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
CES2 O00748 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
KCNK2 O95069 1/20 0.39
LIPC P11150 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4440220 0.95 CFTR (0.54) CFTRMPOKDM4EALDH1A1HPGD
SCHEMBL4436473 0.89 MPO (0.50) MPOKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4440554 0.84 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL15911983 0.82 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL8530063 0.81 ALDH1A1 (0.57) CFTRMPOKDM4EALDH1A1HPGD
SCHEMBL11703013 0.81 KCNQ3 (0.53) CFTRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8535062 0.79 KCNK2 (0.46) MPOKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15911985 0.78 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL4437772 0.78 KEAP1 (0.57) MPOKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4448426 0.77 SLC6A4 (0.51) CFTRKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061754-A1 BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-05-27 EP disclosed
WO-2008115999-A1 BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-09-25 WO disclosed